Quality of life (QOL) with sunitinib versus interferon-alfa (IFN-α) as first-line therapy in patients with metastatic renal cell carcinoma (mRCC): Final results Multivariate analysis performed without ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results